Published in Fortschr Neurol Psychiatr on November 10, 2010
[Behaviour therapy - a changing psychotherapeutic approach]. Fortschr Neurol Psychiatr (2010) 0.75
Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'. Br J Psychiatry (1992) 2.12
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett (1997) 1.71
A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol (2000) 1.61
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French Paradox'? Alcohol Alcohol (2001) 1.50
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna) (2006) 1.43
Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry (1993) 1.41
Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem (2002) 1.40
Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis (1997) 1.37
Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna) (2004) 1.33
BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm (Vienna) (2007) 1.31
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. Neurosci Biobehav Rev (1997) 1.27
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17
Homocysteine and risk of open-angle glaucoma. J Neural Transm (Vienna) (2002) 1.14
QTL analyses of drought tolerance and growth for a Salix dasyclados x Salix viminalis hybrid in contrasting water regimes. Theor Appl Genet (2004) 1.11
Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. AJNR Am J Neuroradiol (2000) 1.10
Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology (2000) 1.08
Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence. Hum Mol Genet (2005) 1.07
Age-dependent memory loss, synaptic pathology and altered brain plasticity in the Drosophila mutant cardinal accumulating 3-hydroxykynurenine. J Neural Transm (Vienna) (2000) 1.06
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology (2009) 1.05
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol Psychiatry (2007) 1.05
Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord (2010) 1.04
Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol (1999) 1.04
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm (Vienna) (2007) 1.02
Effects of peer-assisted training during the neurology clerkship: a randomized controlled study. Eur J Neurol (2008) 1.01
Potential genetic markers of sporadic Alzheimer's dementia. Psychiatr Genet (2001) 0.99
Biological markers to predict previous alcohol withdrawal seizures: a risk assessment. J Neural Transm (Vienna) (2006) 0.98
[Quality improvement of multiple choice examinations: in psychiatry, psychosomatic medicine, psychotherapy, and neurology]. Nervenarzt (2009) 0.98
Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem (1999) 0.97
Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry (2010) 0.96
Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett (1998) 0.95
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm (Vienna) (2005) 0.94
Inhibition of Na(+),K(+)-ATPase activity in cultured rat cerebellar granule cells prevents the onset of apoptosis induced by low potassium. Neurosci Lett (2000) 0.94
Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry (2003) 0.93
Dopamine/glutamate interactions in Parkinson's disease. Neurosci Biobehav Rev (1997) 0.93
Homocysteine and alcoholism. J Neural Transm Suppl (2000) 0.93
Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol (2000) 0.93
Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. J Biol Chem (2001) 0.92
Homocysteine induces cell death of rat astrocytes in vitro. Neurosci Lett (2003) 0.92
A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. Med Hypotheses (1992) 0.90
Increased homocysteine levels in tear fluid of patients with primary open-angle glaucoma. Ophthalmic Res (2008) 0.90
Blue light improves cognitive performance. J Neural Transm (Vienna) (2007) 0.89
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect (1993) 0.89
Pneumococcal cell wall components induce nitric oxide synthase and TNF-alpha in astroglial-enriched cultures. Glia (1996) 0.89
Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma. J Neural Transm (Vienna) (2006) 0.89
Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats. Neurosci Lett (1995) 0.88
Preoptic catecholamine, GABA, and glutamate release in ovariectomized and ovariectomized estrogen-primed rats utilizing a push-pull cannula technique. Neuroendocrinology (1985) 0.88
A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res (1996) 0.88
Positive correlation between contamination by blood and amino acid levels in cerebrospinal fluid of the rat. Neurosci Lett (1986) 0.88
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. J Neural Transm (Vienna) (2006) 0.88
Ghrelin and eating disturbances in psychiatric disorders. Neuropsychobiology (2008) 0.88
Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI study. Alcohol Alcohol (2003) 0.88
Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site. J Med Chem (1998) 0.88
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism. Neurosci Lett (2003) 0.87
Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry (2005) 0.87
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia. Arzneimittelforschung (1992) 0.87
The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics. J Neural Transm (Vienna) (2006) 0.87
Cardiac effects of vagus nerve stimulation in patients with major depression. Pharmacopsychiatry (2009) 0.86
Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry (2009) 0.86
Leptin is associated with craving in females with alcoholism. Addict Biol (2004) 0.86
CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm (Vienna) (2004) 0.86
Plasma homocysteine is a predictor of alcohol withdrawal seizures. Neuroreport (2000) 0.86
The cortico-nigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res (1984) 0.86
Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa. Mol Psychiatry (2007) 0.85
Prospective case control study on genetic assocation of apolipoprotein epsilon2 with intraocular pressure. Br J Ophthalmol (2004) 0.85
Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures. FASEB J (2000) 0.85
Spontaneous slow and fast MEG activity in male schizophrenics treated with clozapine. Psychopharmacology (Berl) (1999) 0.85
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging (2012) 0.85
Gastric nonabsorbable indicators in man: a comparison of phenol red and polyethylene- 14 C glycol. Scand J Gastroenterol (1973) 0.84
Reduced CSF carboxyterminally truncated Abeta peptides in frontotemporal lobe degenerations. J Neural Transm (Vienna) (2007) 0.84
[Pathophysiology and therapy of malignant neuroleptic syndrome]. Nervenarzt (1992) 0.84
Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. J Neural Transm (Vienna) (2005) 0.84
Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur Arch Psychiatry Clin Neurosci (1991) 0.83
Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients. Mol Psychiatry (2007) 0.83
A negative personal and family history for venous thrombotic events is not sufficient to exclude thrombophilia in patients with cerebral venous thrombosis. Eur J Neurol (2004) 0.83
[Adolf Abraham Gustav Bingel (1901-1982): pioneer of electroconvulsive treatment in Germany]. Fortschr Neurol Psychiatr (2013) 0.83
Axo-axonic synapses in the rat striatum. Eur Neurol (1983) 0.83
Rapid Ca2+-dependent NO-production from central nervous system cells in culture measured by NO-nitrite/ozone chemoluminescence. Brain Res (1997) 0.83
In vivo release of neurotransmitters in the medial basal hypothalamus of the monkey. Exp Brain Res (1984) 0.82
Olanzapine treatment of obsessive-compulsive disorder. Can J Psychiatry (2000) 0.82
Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J Neural Transm (Vienna) (2007) 0.82
Variations of monoamines and their metabolites in the human brain putamen. Brain Res (1992) 0.82
[Frontotemporal dementia: neurotransmitter and clinical symptoms with focus on therapeutic targets]. Fortschr Neurol Psychiatr (2009) 0.81
A common molecular machinery for exocytosis and the 'kiss-and-run' mechanism in chromaffin cells is controlled by phosphorylation. J Cell Sci (2001) 0.81
Lithium decreases secretion of Abeta1-42 and C-truncated species Abeta1-37/38/39/40 in chicken telencephalic cultures but specifically increases intracellular Abeta1-38. Neurodegener Dis (2004) 0.81
[Long-term analysis of disability pensions in survivors of the Holocaust: somatic and psychiatric diagnoses]. Fortschr Neurol Psychiatr (2010) 0.81
Dopamine and N-methyl-D-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal. J Neural Transm (Vienna) (2007) 0.81
Time perception in patients with major depressive disorder during vagus nerve stimulation. Pharmacopsychiatry (2011) 0.81
Pharmacotoxic psychosis after memantine in Parkinson's disease. Lancet (1991) 0.81
Homocysteine plasma levels are elevated in females with anorexia nervosa. J Neural Transm (Vienna) (2005) 0.80
Oxidative stress and an altered methionine metabolism in alcoholism. Neurosci Lett (2000) 0.80
Blood-cerebrospinal fluid barrier in schizophrenic patients. Eur Arch Psychiatry Neurol Sci (1987) 0.80
Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. J Affect Disord (1992) 0.80
Glutamic acid diethyl ester induces catalepsy in rats. A new model for schizophrenia? Neurosci Lett (1982) 0.80
Neuroprotective effects of the antifungal drug clotrimazole. Neuroscience (2002) 0.80